Work

A phase I trial of SAR650984, a CD38 monoclonal antibody, in relapsed or refractory multiple myeloma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.8532

Authors: Thomas G. Martin, Karl Hsu, Stephen Anthony Strickland, Martha Jane Glenn, Joseph Mikhael, Eric Charpentier

Institutions: University of San Francisco, Vanderbilt University Medical Center, Huntsman Cancer Institute, Mayo Clinic, Mayo Clinic in Arizona

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2533263660

Cites:

Cited by: 49

Related to: 10